Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Ruud Dings

Concepts (317)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Angiogenesis Inhibitors
25
2022
183
3.950
Why?
Proteins
17
2010
348
2.360
Why?
Neovascularization, Pathologic
17
2022
153
2.350
Why?
Calixarenes
7
2017
9
1.890
Why?
Melanoma, Experimental
6
2021
40
1.790
Why?
Galectin 1
8
2024
21
1.770
Why?
Antineoplastic Agents
14
2024
1222
1.510
Why?
Peptides
20
2017
223
1.330
Why?
Mice
47
2024
5949
1.230
Why?
Neoplasms
14
2024
1325
1.150
Why?
Endothelial Cells
10
2022
262
1.020
Why?
Animals
53
2024
13505
1.010
Why?
Lung Neoplasms
5
2024
636
0.990
Why?
Gold
7
2023
128
0.850
Why?
Ovarian Neoplasms
8
2008
459
0.850
Why?
Oxygen
6
2020
336
0.830
Why?
Cell Line, Tumor
18
2024
1470
0.770
Why?
Carcinoma, Non-Small-Cell Lung
1
2024
170
0.750
Why?
Carcinoma, Squamous Cell
4
2019
332
0.730
Why?
Proto-Oncogene Proteins c-met
1
2021
19
0.710
Why?
Peptide Fragments
5
2013
203
0.700
Why?
Mammary Neoplasms, Experimental
6
2015
122
0.690
Why?
Radiation-Sensitizing Agents
4
2023
52
0.690
Why?
Head and Neck Neoplasms
3
2019
288
0.660
Why?
Carcinoma, Lewis Lung
1
2019
9
0.650
Why?
Molecular Targeted Therapy
2
2018
133
0.630
Why?
Preservation, Biological
1
2018
9
0.620
Why?
Lymphocytes, Tumor-Infiltrating
1
2019
78
0.620
Why?
Protein Kinase Inhibitors
1
2021
227
0.610
Why?
Radiation Tolerance
5
2020
84
0.600
Why?
CD8-Positive T-Lymphocytes
1
2019
132
0.600
Why?
Anti-Bacterial Agents
4
2019
807
0.600
Why?
Galectins
1
2018
7
0.590
Why?
Metal Nanoparticles
4
2023
86
0.550
Why?
Hyperthermia, Induced
3
2019
120
0.540
Why?
Bacteria
1
2018
228
0.530
Why?
Mice, Nude
12
2019
265
0.530
Why?
Radiotherapy
5
2021
127
0.520
Why?
Xenograft Model Antitumor Assays
11
2020
220
0.500
Why?
Pseudomonas aeruginosa
2
2013
78
0.470
Why?
Combined Modality Therapy
11
2020
639
0.420
Why?
Benzofurans
2
2012
18
0.420
Why?
Cytotoxins
1
2013
15
0.410
Why?
Cell Proliferation
10
2024
1023
0.400
Why?
Drug Design
4
2014
120
0.400
Why?
Pseudomonas Infections
1
2013
54
0.400
Why?
Oxidation-Reduction
3
2024
326
0.400
Why?
Endothelium, Vascular
8
2010
246
0.400
Why?
Carbohydrate Metabolism
1
2012
23
0.390
Why?
Humans
44
2024
52483
0.390
Why?
Neoplasms, Experimental
4
2020
114
0.380
Why?
Nanostructures
3
2023
48
0.380
Why?
Benzeneacetamides
2
2024
12
0.380
Why?
Glutaminase
2
2024
18
0.380
Why?
Bacteremia
1
2013
92
0.380
Why?
Sesquiterpenes
3
2010
90
0.360
Why?
Angiostatic Proteins
1
2011
1
0.360
Why?
Immunity, Cellular
1
2011
64
0.350
Why?
Molecular Mimicry
2
2007
38
0.340
Why?
Cell Survival
8
2024
612
0.340
Why?
Dendritic Cells
3
2021
136
0.340
Why?
Endothelium
4
2022
37
0.330
Why?
Carboplatin
3
2024
57
0.320
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2008
1031
0.320
Why?
Tumor Necrosis Factor-alpha
4
2019
399
0.320
Why?
Immunotherapy, Adoptive
1
2011
166
0.310
Why?
Cells, Cultured
8
2013
1567
0.310
Why?
Vascular Endothelial Growth Factor A
7
2022
182
0.310
Why?
Apoptosis
7
2024
1119
0.310
Why?
Intercellular Adhesion Molecule-1
5
2022
61
0.300
Why?
T-Lymphocytes
1
2011
340
0.300
Why?
Structure-Activity Relationship
6
2012
404
0.300
Why?
Polyethylene Glycols
3
2021
90
0.300
Why?
Mice, Inbred C57BL
8
2021
1884
0.290
Why?
Phototherapy
2
2019
42
0.290
Why?
Amino Acid Sequence
5
2012
578
0.280
Why?
Tumor Cells, Cultured
6
2019
460
0.280
Why?
Female
24
2020
28171
0.270
Why?
Drug Resistance, Neoplasm
2
2024
326
0.270
Why?
Magnetic Resonance Spectroscopy
5
2012
253
0.260
Why?
Blood Vessels
4
2015
71
0.260
Why?
Antibodies, Monoclonal
2
2007
481
0.260
Why?
Molecular Sequence Data
5
2012
778
0.250
Why?
Disease Models, Animal
7
2020
1478
0.240
Why?
Nanoparticles
2
2017
160
0.230
Why?
Cell Division
7
2010
291
0.220
Why?
Bystander Effect
1
2024
25
0.220
Why?
Cysteine
1
2024
49
0.220
Why?
Buthionine Sulfoximine
1
2024
13
0.220
Why?
Human Umbilical Vein Endothelial Cells
3
2014
99
0.220
Why?
Nanotubes
2
2021
27
0.220
Why?
Models, Molecular
4
2024
348
0.210
Why?
Thiadiazoles
2
2024
18
0.210
Why?
Flow Cytometry
2
2017
478
0.200
Why?
Cisplatin
1
2024
285
0.190
Why?
Alanine
3
2012
44
0.190
Why?
Protein Binding
3
2012
667
0.190
Why?
Carcinoma, Renal Cell
1
2022
111
0.190
Why?
Binding Sites
2
2012
377
0.180
Why?
Optical Imaging
2
2020
26
0.180
Why?
Polyurethanes
1
2021
10
0.180
Why?
Silver
2
2021
52
0.180
Why?
Kidney Neoplasms
1
2022
182
0.180
Why?
Radiation
1
2020
14
0.180
Why?
Forkhead Transcription Factors
1
2021
116
0.170
Why?
Materials Testing
1
2021
58
0.170
Why?
Spectrum Analysis
1
2020
69
0.170
Why?
Biocompatible Materials
1
2021
67
0.170
Why?
Mice, Inbred BALB C
5
2020
312
0.170
Why?
CD4-Positive T-Lymphocytes
1
2021
164
0.170
Why?
Neoplasm Transplantation
5
2007
87
0.160
Why?
Mice, Knockout
3
2012
879
0.160
Why?
Oxygen Consumption
1
2020
198
0.160
Why?
Disease Progression
3
2019
871
0.160
Why?
Lactose
2
2024
8
0.160
Why?
Spectrum Analysis, Raman
1
2019
56
0.150
Why?
Specimen Handling
1
2018
56
0.150
Why?
Immunotherapy
1
2020
244
0.150
Why?
Biological Assay
1
2018
47
0.150
Why?
Time Factors
6
2017
2968
0.150
Why?
Drug Delivery Systems
2
2019
154
0.150
Why?
Indazoles
1
2018
47
0.140
Why?
Carbohydrates
1
2018
41
0.140
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2018
59
0.140
Why?
Feces
1
2018
153
0.140
Why?
Temperature
1
2018
183
0.140
Why?
Cell Hypoxia
4
2015
83
0.140
Why?
Histocompatibility Antigens Class II
1
2017
36
0.140
Why?
Tumor Microenvironment
1
2019
256
0.130
Why?
Drug Therapy, Combination
1
2018
395
0.130
Why?
Neoplastic Cells, Circulating
1
2017
74
0.130
Why?
Epithelial Cells
1
2018
215
0.130
Why?
Male
9
2019
26761
0.130
Why?
Cell Line
4
2017
1030
0.130
Why?
Lipopolysaccharides
2
2008
206
0.130
Why?
Umbilical Veins
4
2010
21
0.130
Why?
Enzyme Inhibitors
1
2018
372
0.130
Why?
Leukocytes
3
2006
66
0.120
Why?
Molecular Imaging
1
2015
55
0.120
Why?
Azides
1
2014
9
0.120
Why?
Fluorine Radioisotopes
1
2014
25
0.120
Why?
Tumor Burden
2
2013
136
0.120
Why?
Cell Transformation, Neoplastic
2
2007
184
0.110
Why?
Immunohistochemistry
5
2020
979
0.110
Why?
Interleukin-2
2
2021
69
0.110
Why?
Drug Synergism
2
2005
150
0.110
Why?
Cell Adhesion
3
2006
163
0.110
Why?
Piperacillin
1
2013
23
0.100
Why?
Peptidomimetics
1
2012
2
0.100
Why?
Penicillanic Acid
1
2013
20
0.100
Why?
Agglutination Tests
1
2012
5
0.100
Why?
Allosteric Regulation
1
2012
16
0.100
Why?
Inflammation Mediators
1
2013
115
0.100
Why?
Cell Cycle
1
2013
230
0.090
Why?
Antimicrobial Cationic Peptides
2
2008
29
0.090
Why?
Up-Regulation
2
2011
454
0.090
Why?
Neoplastic Stem Cells
1
2012
99
0.090
Why?
Partial Pressure
1
2011
14
0.090
Why?
Metformin
1
2012
76
0.090
Why?
Glutamine
2
2024
176
0.090
Why?
Adjuvants, Immunologic
1
2011
52
0.090
Why?
Fibroblasts
1
2013
355
0.090
Why?
Chemotherapy, Adjuvant
1
2011
124
0.090
Why?
Cell Movement
4
2006
268
0.080
Why?
Spiro Compounds
1
2010
8
0.080
Why?
Cytokines
1
2013
623
0.080
Why?
Lignans
1
2008
7
0.080
Why?
Salmonella typhimurium
1
2008
42
0.070
Why?
Klebsiella pneumoniae
1
2008
20
0.070
Why?
Amino Acid Substitution
1
2008
82
0.070
Why?
Furans
1
2008
30
0.070
Why?
Surface Properties
1
2007
62
0.070
Why?
Escherichia coli
1
2008
192
0.070
Why?
Angiostatins
2
2006
2
0.070
Why?
Endotoxins
1
2006
21
0.070
Why?
Vascular Neoplasms
1
2007
17
0.070
Why?
Concept Formation
1
2006
12
0.070
Why?
Gram-Negative Bacteria
1
2006
35
0.070
Why?
Protein Structure, Secondary
2
2003
71
0.070
Why?
Interleukin-8
1
2006
86
0.060
Why?
Genes, Synthetic
1
2005
1
0.060
Why?
Protein Engineering
1
2005
20
0.060
Why?
Antibodies, Monoclonal, Humanized
1
2007
236
0.060
Why?
Cloning, Molecular
1
2005
190
0.060
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2006
145
0.060
Why?
Angiogenic Proteins
1
2004
6
0.060
Why?
Protein Unfolding
1
2024
7
0.060
Why?
Colonic Neoplasms
1
2006
163
0.060
Why?
Dietary Supplements
1
2008
465
0.060
Why?
Disulfides
1
2024
17
0.060
Why?
Histones
1
2006
314
0.060
Why?
Feasibility Studies
1
2006
406
0.060
Why?
Diphtheria Toxin
1
2004
4
0.060
Why?
Mutagenesis, Site-Directed
1
2024
95
0.060
Why?
Protein Folding
1
2024
50
0.060
Why?
Mammary Neoplasms, Animal
1
2004
35
0.060
Why?
Osmosis
1
2003
5
0.050
Why?
Infusion Pumps
1
2003
13
0.050
Why?
Circular Dichroism
1
2003
42
0.050
Why?
Plasminogen
1
2003
3
0.050
Why?
Serum Albumin
1
2003
58
0.050
Why?
Dose-Response Relationship, Drug
2
2004
1378
0.050
Why?
Extracellular Matrix
1
2003
112
0.050
Why?
Immune Tolerance
1
2022
91
0.050
Why?
Gene Expression Regulation, Neoplastic
4
2008
857
0.050
Why?
Reactive Oxygen Species
1
2024
421
0.050
Why?
Endostatins
3
2007
4
0.050
Why?
Neoplasm Invasiveness
1
2022
278
0.050
Why?
Immune System
1
2021
42
0.050
Why?
Immunity
1
2021
39
0.050
Why?
Ethers
1
2021
8
0.040
Why?
Melanoma
1
2004
288
0.040
Why?
Regenerative Medicine
1
2021
12
0.040
Why?
Tissue Scaffolds
1
2021
40
0.040
Why?
Angiogenesis Inducing Agents
1
2000
7
0.040
Why?
Dose-Response Relationship, Radiation
1
2020
184
0.040
Why?
Tissue Engineering
1
2021
74
0.040
Why?
Bone Marrow Cells
1
2021
190
0.040
Why?
Adenocarcinoma
1
2004
405
0.040
Why?
Mice, Inbred C3H
2
2012
83
0.040
Why?
Gene Expression Profiling
1
2004
1105
0.040
Why?
Skin Neoplasms
1
2004
505
0.040
Why?
Flavin-Adenine Dinucleotide
1
2018
4
0.040
Why?
NAD
1
2018
45
0.040
Why?
Inflammation
1
2022
641
0.040
Why?
Microcirculation
2
2010
64
0.040
Why?
Guidelines as Topic
1
2018
111
0.040
Why?
Glutathione
1
2019
305
0.040
Why?
Microscopy, Fluorescence
1
2018
160
0.030
Why?
Phagocytosis
1
2017
53
0.030
Why?
Glycolysis
1
2017
73
0.030
Why?
Transplantation, Heterologous
2
2008
79
0.030
Why?
Clonal Anergy
2
2006
13
0.030
Why?
Extracellular Fluid
1
2015
14
0.030
Why?
Nitroimidazoles
1
2015
16
0.030
Why?
Microbubbles
1
2015
25
0.030
Why?
Cell Count
1
2015
149
0.030
Why?
Stromal Cells
1
2015
79
0.030
Why?
Pressure
1
2015
104
0.030
Why?
Down-Regulation
2
2006
346
0.030
Why?
Paclitaxel
2
2006
89
0.030
Why?
Drug Evaluation, Preclinical
1
2015
146
0.030
Why?
Cycloaddition Reaction
1
2014
1
0.030
Why?
Radiochemistry
1
2014
2
0.030
Why?
Click Chemistry
1
2014
3
0.030
Why?
Random Allocation
1
2015
285
0.030
Why?
Recombinant Proteins
2
2006
483
0.030
Why?
Radiotherapy Dosage
1
2015
255
0.030
Why?
Cell Differentiation
1
2017
665
0.030
Why?
Imaging, Three-Dimensional
1
2015
154
0.030
Why?
Contrast Media
1
2015
193
0.030
Why?
Molecular Structure
1
2014
314
0.030
Why?
Ultrasonography
1
2015
430
0.030
Why?
Chromatography, High Pressure Liquid
1
2014
339
0.030
Why?
Ribosomal Protein S6 Kinases
1
2012
8
0.020
Why?
Adenylate Kinase
1
2012
9
0.020
Why?
TOR Serine-Threonine Kinases
1
2012
80
0.020
Why?
Rats
2
2008
3220
0.020
Why?
Radiometry
1
2012
127
0.020
Why?
4-Butyrolactone
1
2008
5
0.020
Why?
Butylene Glycols
1
2008
14
0.020
Why?
Phytoestrogens
1
2008
23
0.020
Why?
9,10-Dimethyl-1,2-benzanthracene
1
2008
50
0.020
Why?
Ovariectomy
1
2008
113
0.020
Why?
Receptors, Progesterone
1
2008
66
0.020
Why?
Estrogen Receptor beta
1
2008
54
0.020
Why?
Estrogen Receptor alpha
1
2008
85
0.020
Why?
Cell Growth Processes
1
2007
22
0.020
Why?
Carcinogens
1
2008
193
0.020
Why?
Horseshoe Crabs
1
2006
3
0.020
Why?
Blood Bactericidal Activity
1
2006
4
0.020
Why?
Lipid A
1
2006
4
0.020
Why?
Polymyxin B
1
2006
4
0.020
Why?
Neutralization Tests
1
2006
27
0.020
Why?
Cytidine
1
2006
5
0.020
Why?
Pyrroles
1
2007
71
0.020
Why?
DNA Modification Methylases
1
2006
28
0.020
Why?
Endotoxemia
1
2006
34
0.020
Why?
Acetylation
1
2006
95
0.020
Why?
Methylation
1
2006
126
0.020
Why?
Vimentin
1
2006
32
0.020
Why?
Chick Embryo
1
2006
81
0.020
Why?
Gene Silencing
1
2006
118
0.020
Why?
Blood Proteins
1
2006
85
0.020
Why?
Nucleic Acid Hybridization
1
2006
56
0.020
Why?
Cyclohexanes
1
2006
4
0.020
Why?
Transfection
1
2007
357
0.020
Why?
Zebrafish
1
2006
59
0.020
Why?
Histone Deacetylase Inhibitors
1
2006
58
0.020
Why?
Histone Deacetylases
1
2006
51
0.020
Why?
Vascular Cell Adhesion Molecule-1
1
2006
39
0.020
Why?
Pichia
1
2005
8
0.020
Why?
Gene Transfer Techniques
1
2005
40
0.020
Why?
Cyclophosphamide
1
2006
171
0.020
Why?
Neovascularization, Physiologic
1
2005
72
0.010
Why?
Sequence Homology, Nucleic Acid
1
2004
47
0.010
Why?
Membrane Proteins
1
2006
335
0.010
Why?
Indoles
1
2007
278
0.010
Why?
Treatment Outcome
1
2014
5422
0.010
Why?
Necrosis
1
2004
176
0.010
Why?
Antibodies
1
2004
159
0.010
Why?
Skin
1
2007
422
0.010
Why?
In Situ Nick-End Labeling
1
2003
53
0.010
Why?
Base Sequence
1
2004
640
0.010
Why?
Sequence Homology, Amino Acid
1
2003
140
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2004
582
0.010
Why?
Epigenesis, Genetic
1
2006
406
0.010
Why?
Mice, Transgenic
1
2004
552
0.010
Why?
RNA, Messenger
1
2004
1132
0.010
Why?
Endothelial Growth Factors
1
2000
9
0.010
Why?
Vascular Endothelial Growth Factors
1
2000
14
0.010
Why?
Fibroblast Growth Factor 2
1
2000
34
0.010
Why?
Lymphokines
1
2000
20
0.010
Why?
Scrotum
1
2000
31
0.010
Why?
Interleukin-1
1
2000
107
0.010
Why?
Models, Biological
1
2002
735
0.010
Why?
Breast Neoplasms
1
2004
1212
0.010
Why?
Dings's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description